UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE 14A
Proxy
Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by
the Registrant [X]
Filed by a Party other than the Registrant [_]
Check the appropriate box:
| [_] | Preliminary Proxy Statement |
| [_] | CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (as permitted by Rule 14a-6(e)(2)) |
| [_] | Definitive Proxy Statement |
| [X] | Definitive Additional Materials |
| [_] | Soliciting Material Pursuant to Section 240.14a-12 |
Pfizer Inc.
|
|
| (Name of Registrant as Specified In Its Charter) |
|
|
| (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) |
Payment of Filing Fee (Check all boxes that apply):
| [X] | No fee required. | |
| [_] | Fee paid previously with preliminary materials | |
| [_] | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 | |
Margaret M. Madden
235 East 42nd Street, New York, NY 10017
YOUR VOTE IS IMPORTANT - PLEASE VOTE YOUR SHARES TODAY
Dear Fellow Pfizer Shareholder:
On April 28, 2022, Pfizer will hold its Annual Meeting of Shareholders. We value your input as a holder of Pfizer common stock and encourage you to review our proxy materials and cast your vote today. You can view our proxy materials at https://investors.pfizer.com/proxy.
For the reasons set forth in the 2022 Proxy Statement, the Board of Directors recommends that you vote:
| ● | “FOR” each director nominee |
| ● | “FOR” the ratification of the selection of KPMG LLP as the independent registered public accounting firm for 2022 |
| ● | “FOR” the 2022 advisory approval of executive compensation |
| ● | “AGAINST” the five shareholder proposals. |
For your convenience, a duplicate proxy/voting instruction card and return envelope are enclosed, along with telephone and Internet voting instructions. In the event that multiple proxies/voting instruction cards are received from you, the one with the latest date will be counted.
The 2022 Annual Meeting will be held in a virtual format only. Please view our proxy statement for details on how you can participate.
Your vote is important and valued. I encourage you to vote in advance of the Annual Meeting by one of the methods described in the proxy materials and duplicate proxy/voting instruction card. Please act today to be sure your shares are voted.
Sincerely,
Margaret M. Madden
Senior Vice President and Corporate Secretary, Chief Governance Counsel
Pfizer Inc. – Legal Division
| Breakthroughs that change patients’ lives | pfizer.com |